salicylanilide has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, A; Chu, LJ; Chu, P; Hua, KF; Huang, HS; Hung, SC; Ka, SM; Kao, CC; Liu, FC; Sung, CC; Tsai, IL; Wei, CW; Wu, ATH; Wu, CY; Yang, SR | 1 |
| Liang, LP; Patel, M; Pearson, JN; Roberts, LJ; Warren, E | 1 |
2 other study(ies) available for salicylanilide and Disease Models, Animal
| Article | Year |
|---|---|
NSC828779 Alleviates Renal Tubulointerstitial Lesions Involving Interleukin-36 Signaling in Mice.
Topics: Animals; Cell Line; Cytokines; Disease Models, Animal; Epithelial Cells; Female; Hydrogen Peroxide; Inflammasomes; Interleukin-1; Lipopolysaccharides; Macrophages; Mice, Inbred C57BL; Molecular Docking Simulation; Nephritis, Interstitial; NLR Family, Pyrin Domain-Containing 3 Protein; Salicylanilides; Signal Transduction; STAT3 Transcription Factor; Ureteral Obstruction | 2021 |
Scavenging of highly reactive gamma-ketoaldehydes attenuates cognitive dysfunction associated with epileptogenesis.
Topics: Aldehydes; Animals; Antioxidants; Cognitive Dysfunction; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Kainic Acid; Ketones; Male; Memory Disorders; Neuroprotective Agents; Pilocarpine; Random Allocation; Rats, Sprague-Dawley; Salicylanilides; Status Epilepticus | 2017 |